Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Nipah virus attachment glycoprotein (NiV-G) is a surface protein essential for viral entry into host cells. It mediates viral attachment by binding to ephrin-B2 and ephrin-B3 receptors, triggering conformational changes that activate the fusion glycoprotein (F) for membrane fusion. NiV-G is a major target for neutralizing antibodies and antiviral drug development due to its critical role in initiating infection.
Disruption of G-ephrin interaction
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nipah virus attachment glycoprotein (NiV-G).